Additional associations in BEAT-AML included slightly lower PSAT1 with mutations in NPM1 and FLT3 and higher PSAT1 with KMT2A rearrangement and MPL mutation (Figure S5A). This evidence concerns the gene FLT3 and acute myeloid leukemia.